USFDA issues Form 483 with 4 observations to Piramal Pharma's Telangana unit
Published on: Feb. 14, 2026, 3:01 p.m. | Source: Daily Excelsior
NEW DELHI, Feb 14: Piramal Pharma has said the US health regulator has issued Form 483 with four observations after inspecting its Telangana-based manufacturing plant. The US Food and Drug Administration (USFDA) conducted an inspection of the company’s Digwal (Telangana ) based plant from February 9, 2026, to February 13, 2026. At the conclusion of the inspection, the USFDA issued a Form-483, with four observations, Piramal Pharma said in a regulatory filing on Friday. These observations are related to enhancement […]
